83 related articles for article (PubMed ID: 7858065)
21. Monoclonal antipeptide antibodies recognize IL-3 and neutralize its bioactivity in vivo.
Ziltener HJ; Clark-Lewis I; Fazekas de St Groth B; Orban PC; Hood LE; Kent SB; Schrader JW
J Immunol; 1988 Feb; 140(4):1182-7. PubMed ID: 3257773
[TBL] [Abstract][Full Text] [Related]
22. Development and characterization of two neutralizing monoclonal antibodies to human interleukin-1 alpha.
Stya M; Dower SK; Prickett KS; Gillis S; Conlon PJ
J Biol Response Mod; 1988 Apr; 7(2):162-72. PubMed ID: 3258906
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo characterisation of anti-murine IL-13 antibodies recognising distinct functional epitopes.
Berry LM; Adams R; Airey M; Bracher MG; Bourne T; Carrington B; Cross AS; Davies GC; Finney HM; Foulkes R; Gozzard N; Griffin RA; Hailu H; Lamour SD; Lawson AD; Lightwood DJ; McKnight AJ; O'Dowd VL; Oxbrow AK; Popplewell AG; Shaw S; Stephens PE; Sweeney B; Tomlinson KL; Uhe C; Palframan RT
Int Immunopharmacol; 2009 Feb; 9(2):201-6. PubMed ID: 19041426
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
[TBL] [Abstract][Full Text] [Related]
25. Functional idiotypic mimicry of an adhesion- and differentiation-promoting site on acetylcholinesterase.
Johnson G; Moore SW
J Cell Biochem; 2004 Apr; 91(5):999-1009. PubMed ID: 15034934
[TBL] [Abstract][Full Text] [Related]
26. The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen.
Tsujisaki M; Hinoda Y; Tokuchi S; Hanzawa Y; Arimura Y; Masuya J; Kitagawa H; Okochi E; Shimamura T; Hamuro J
J Immunol; 1993 Jan; 150(2):508-16. PubMed ID: 8419483
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the cytokine network among tumor necrosis factor alpha, interleukin-1beta, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Maeda T; Takahashi T; Ohkawara S; Yoshinaga M
Lab Invest; 1998 May; 78(5):559-69. PubMed ID: 9605181
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibodies reacting with the interleukin 1 receptor define a multi-molecular complex.
Lewis C; Mazzei G; Shaw A
Eur J Immunol; 1990 Jan; 20(1):207-13. PubMed ID: 2137781
[TBL] [Abstract][Full Text] [Related]
29. Analysis of human IL-2/IL-2 receptor beta chain interactions: monoclonal antibody H2-8 and new IL-2 mutants define the critical role of alpha helix-A of IL-2.
Eckenberg R; Xu D; Moreau JL; Bossus M; Mazie JC; Tartar A; Liu XY; Alzari PM; Bertoglio J; Theze J
Cytokine; 1997 Jul; 9(7):488-98. PubMed ID: 9237811
[TBL] [Abstract][Full Text] [Related]
30. Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis.
Dahlén E; Barchan K; Herrlander D; Höjman P; Karlsson M; Ljung L; Andersson M; Bäckman E; Hager AC; Walse B; Joosten L; van den Berg W
J Immunotoxicol; 2008 Apr; 5(2):189-99. PubMed ID: 18569390
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
[TBL] [Abstract][Full Text] [Related]
32. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
33. Endogenous interleukin-1 receptor antagonist is neuroprotective.
Loddick SA; Wong ML; Bongiorno PB; Gold PW; Licinio J; Rothwell NJ
Biochem Biophys Res Commun; 1997 May; 234(1):211-5. PubMed ID: 9168991
[TBL] [Abstract][Full Text] [Related]
34. The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.
Dower SK; Kronheim SR; Hopp TP; Cantrell M; Deeley M; Gillis S; Henney CS; Urdal DL
Nature; 1986 Nov 20-26; 324(6094):266-8. PubMed ID: 2946959
[TBL] [Abstract][Full Text] [Related]
35. Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivo.
Hogquist KA; Nett MA; Sheehan KC; Pendleton KD; Schreiber RD; Chaplin DD
J Immunol; 1991 Mar; 146(5):1534-40. PubMed ID: 1993843
[TBL] [Abstract][Full Text] [Related]
36. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
[TBL] [Abstract][Full Text] [Related]
37. Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.
Tam FW; Smith J; Cashman SJ; Wang Y; Thompson EM; Rees AJ
Am J Pathol; 1994 Jul; 145(1):126-36. PubMed ID: 8030744
[TBL] [Abstract][Full Text] [Related]
38. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression.
Pantschenko AG; Pushkar I; Anderson KH; Wang Y; Miller LJ; Kurtzman SH; Barrows G; Kreutzer DL
Int J Oncol; 2003 Aug; 23(2):269-84. PubMed ID: 12851675
[TBL] [Abstract][Full Text] [Related]
39. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
Levine SJ; Wu T; Shelhamer JH
J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D
J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
